骨质疏松症的联合及序贯治疗 - Suppr

Suppr

超能文献

Combination and sequential therapy for osteoporosis.

作者信息

Heaney Robert P, Recker Robert R

出版信息

N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.

DOI:10.1056/NEJMe058154

PMID:16093472

Abstract

摘要

相似文献

Combination and sequential therapy for osteoporosis.骨质疏松症的联合及序贯治疗

N Engl J Med. 2005 Aug 11;353(6):624-5. doi: 10.1056/NEJMe058154.

Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.甲状旁腺激素和阿仑膦酸钠单独或联合使用对骨质疏松症的影响。

N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.

[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].[甲状旁腺与骨骼。骨质疏松症患者甲状旁腺治疗的证据与前景]

Clin Calcium. 2007 Dec;17(12):1888-94.

Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.甲状旁腺激素与阿仑膦酸钠单独或联合应用对骨质疏松症的影响。

N Engl J Med. 2004 Jan 8;350(2):189-92; author reply 189-92.

Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.利用并绕过骨重塑周期以优化骨质疏松症的治疗。

J Bone Miner Res. 1997 Aug;12(8):1152-4. doi: 10.1359/jbmr.1997.12.8.1152.

Daily and cyclic parathyroid hormone in women receiving alendronate.接受阿仑膦酸盐治疗的女性的每日及周期性甲状旁腺激素

N Engl J Med. 2005 Aug 11;353(6):566-75. doi: 10.1056/NEJMoa050157.

Parathyroid hormone plus alendronate--a combination that does not add up.甲状旁腺激素加阿仑膦酸盐——一种不合理的组合。

N Engl J Med. 2003 Sep 25;349(13):1277-9. doi: 10.1056/NEJMe038143. Epub 2003 Sep 20.

Sequential parathyroid hormone/alendronate therapy for osteoporosis--robbing Peter to pay Paul?序贯甲状旁腺激素/阿仑膦酸盐治疗骨质疏松症——拆东墙补西墙？

J Clin Endocrinol Metab. 2000 Jun;85(6):2127-8. doi: 10.1210/jcem.85.6.6658.

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.甲状旁腺激素（1-84）治疗骨质疏松症一年后再使用阿仑膦酸钠一年。

N Engl J Med. 2005 Aug 11;353(6):555-65. doi: 10.1056/NEJMoa050336.

Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year.阿仑膦酸钠对原发性胆汁性肝硬化合并骨质疏松症患者骨量的影响：一年后的初步结果

Scand J Gastroenterol. 2005 Jul;40(7):873-4. doi: 10.1080/00365520510023279.

引用本文的文献

Cost-Effectiveness of Sequential Teriparatide/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.序贯特立帕肽/唑来膦酸对比唑来膦酸单药治疗中国绝经后骨质疏松女性的成本效果分析。

Front Public Health. 2022 Feb 24;10:794861. doi: 10.3389/fpubh.2022.794861. eCollection 2022.

Profile of teriparatide in the management of postmenopausal osteoporosis.特立帕肽在绝经后骨质疏松症治疗中的应用概况。

Int J Womens Health. 2010 Aug 9;2:37-44. doi: 10.2147/ijwh.s4919.

The use of parathyroid hormone in the treatment of osteoporosis.甲状旁腺激素在骨质疏松症治疗中的应用。

Rev Endocr Metab Disord. 2006 Jun;7(1-2):113-21. doi: 10.1007/s11154-006-9007-z.

Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.用于骨质疏松症的合成代谢和抗吸收骨骼药物的联合/序贯疗法。

Curr Osteoporos Rep. 2006 Mar;4(1):5-13. doi: 10.1007/s11914-006-0009-2.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验